Pharmaceutical companies confirm investments in Mexico

President Claudia Sheinbaum announced that, in line with the “Plan Mexico,” the pharmaceutical industry will invest US$1.213 billion in the country, earmarked for seven drug production projects, which are also linked to clinical research.

The president emphasized that the plan’s objective is to produce more than is consumed in Mexico, enabling exports to other countries—not just the United States—while also diversifying exports and strengthening the national pharmaceutical industry. This is a long-term project that will help lower drug costs.

Given the global reliance on China and India for the production of Active Pharmaceutical Ingredients (APIs), Mexico has everything necessary to become a key player in this development.

Undersecretary of Health Eduardo Clark added that there is a portfolio of nearly 10 joint investment projects being promoted by the Ministry of Health in collaboration with both domestic and international industry.

During the morning press briefing, each company detailed the resources it will invest in the country and its commitment to continue investing.